JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grosse Hartlage, M. A.
Right arrow Articles by Weber, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grosse Hartlage, M. A.
Right arrow Articles by Weber, T. P.
Related Collections
Right arrow Cardiovascular
Right arrow Resuscitation
Right arrow Pharmacology

Anesth Analg 2006;103:822-832
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000237246.40665.34

CARDIOVASCULAR ANESTHESIA

{kappa}-Opioid Receptor Antagonism Improves Recovery from Myocardial Stunning in Chronically Instrumented Dogs

Maike A. Grosse Hartlage, MD*, Marc M. Theisen, MD*, Nelson P. Monteiro de Oliveira*, Hugo Van Aken, MD, FRCA, FRANZCA*, Manfred Fobker, MD{dagger}, and Thomas P. Weber, MD*

From the *Department of Anaesthesiology and Intensive Care; and {dagger}Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Münster, Münster, Germany.

Address correspondence and reprint requests to Maike A. Grosse Hartlage, MD, Universitätsklinikum Münster, Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Albert-Schweitzer-Straße 33, 48149 Münster, Germany. Address e-mail to grosse.hartlage{at}anit.uni-muenster.de.

We tested the hypothesis that the selective {kappa}-opioid receptor antagonist nor-binaltorphimine (nor-BNI) improves recovery from myocardial stunning. Ten dogs were chronically instrumented for measurement of heart rate, left atrial, aortic and left ventricular pressure (LVP), and the maximum rate of LVP increase (LV dP/dtmax) and decrease (LV dP/dtmax), coronary blood flow velocity and myocardial wall-thickening fraction. Regional myocardial blood flow was determined with fluorescent microspheres. Catecholamine plasma levels were measured by high-performance liquid chromatography, and ß-endorphin and dynorphin plasma levels by radioimmunoassay. An occluder around the left anterior descending artery (LAD) allowed induction of a reversible LAD-ischemia. Animals underwent two experiments in a randomized crossover fashion on separate days: (a) 10 min LAD-occlusion (control experiment), (b) second ischemic episode 24 h after nor-BNI (2.5 mg/kg IV) (intervention). Dogs receiving nor-BNI showed an increase in wall-thickening fraction, LV dP/dtmax and LV dP/dtmin before ischemia and during the whole reperfusion (P < 0.05 versus control experiment). After nor-BNI pretreatment, dynorphin levels increased after induction of ischemia to a peak level of 15.1 ± 3.6 pg/mL (P < 0.05 versus control experiment). The increase in plasma ß-endorphin during ischemia and early reperfusion was attenuated after nor-BNI. Compared with the control experiment, nor-BNI left global hemodynamics, regional myocardial blood flow, and catecholamine levels unchanged. In conclusion, nor-BNI improves recovery from myocardial stunning after regional myocardial ischemia in chronically instrumented dogs.






Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2006 by the International Anesthesia Research Society.